Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Chief Financial Officer | Common Stock | 29.3K | $318K | $10.85 | Sep 3, 2024 | Direct |
IOVANCE BIOTHERAPEUTICS, INC. | Chief Financial Officer | Restricted Stock Units | 23.4K | $203K | $8.68 | Sep 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Sep 3, 2024 | 3 | -$129K | 4 | Sep 5, 2024 | Chief Financial Officer |
IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Mar 1, 2024 | 2 | $0 | 4 | Mar 5, 2024 | Chief Financial Officer |
IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Mar 2, 2023 | 1 | $0 | 4 | Mar 6, 2023 | Chief Financial Officer |
IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Jan 3, 2023 | 3 | -$64.5K | 4 | Jan 5, 2023 | Chief Financial Officer |
IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Jun 14, 2022 | 3 | -$72.2K | 4 | Jun 16, 2022 | Chief Financial Officer |
IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Jan 14, 2022 | 1 | $0 | 4 | Jan 19, 2022 | Chief Financial Officer |
IOVA | IOVANCE BIOTHERAPEUTICS, INC. | Jun 14, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Chief Financial Officer |